Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
Cancer Research|January 28, 2004
Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude miceAngus M Tester, Mark Waltham, Se-Jeong Oh, et al.Breast Cancer Research and Treatment|April 16, 2026
In vivo exposure to CXCL12-high CAFs and chronic CXCL12 stimulation in vitro is sufficient to enhance metastasis of ER-positive breast cancerPhilip C Miller, Utsav Sharma, JiaXiang Tao, et al.Cancer Research|October 17, 2015
Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast CancerZheng Ao, Sanket H Shah, Leah M Machlin, et al.Diabetes & Vascular Disease Research|April 7, 2010
Inflammatory stress in primary venous and aortic endothelial cells of type 1 diabetic miceLoredana G Bucciarelli, Andreas Pollreisz, Moritz Kebschull, et al.Diabetes & Vascular Disease Research|November 25, 2005
RAGE and its ligands: a lasting memory in diabetic complications?Shi-Fang Yan, Ravichandran Ramasamy, Loredana G Bucciarelli, et al.Atherosclerosis|September 21, 2014
High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan StudyEduard Tiozzo, Hannah Gardener, Barry I Hudson, et al.Atherosclerosis|February 15, 2011
Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS)Barry I Hudson, Yeseon Park Moon, Anastasia Z Kalea, et al.Stroke|May 12, 2016
Subfractions of High-Density Lipoprotein-Cholesterol and Carotid Intima-Media Thickness: The Northern Manhattan StudyEduard Tiozzo, Hannah Gardener, Barry I Hudson, et al.Archives of Biochemistry and Biophysics|October 22, 2003
Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disordersBarry I Hudson, Loredana G Bucciarelli, Thoralf Wendt, et al.Breast Cancer Research and Treatment|October 2, 2014
Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcomeKatherine Drews-Elger, Elizabeth Iorns, Alexandra Dias, et al.Pageof 9